Foresite Capital Management II as of Dec. 31, 2016
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 9 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 39.4 | $78M | 3.8M | 20.45 | |
| Aerie Pharmaceuticals | 29.9 | $60M | 1.6M | 37.85 | |
| Alder Biopharmaceuticals | 10.4 | $21M | 995k | 20.80 | |
| Epizyme | 9.3 | $19M | 1.5M | 12.10 | |
| Nanostring Technologies (NSTGQ) | 7.6 | $15M | 679k | 22.30 | |
| Nexvet Biopharma Pub Ltd Co ord | 1.7 | $3.3M | 895k | 3.73 | |
| Zafgen | 1.1 | $2.1M | 664k | 3.18 | |
| Orexigen Therapeutics | 0.5 | $944k | 543k | 1.74 | |
| Acceleron Pharma | 0.2 | $508k | 20k | 25.51 |
